Art

J-GLOBAL ID：201102297441222141   Reference number：11A1812674

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma

多発性骨髄腫の分子重症度分類,予後予測と個人別治療管理のためのファーマコゲノミックス

Author (7)： JOHNSON Sarah K. (Univ. Arkansas for Medical Sci., AR, USA) ,  HEUCK Christoph J. (Univ. Arkansas for Medical Sci., AR, USA) ,  ALBINO Anthony P. (Signal Genetics LLC, NY, USA) ,  QU Pingping (Cancer Res. and Biostatistics, WA, USA) ,  ZHANG Qing (Univ. Arkansas for Medical Sci., AR, USA) ,  BARLOGIE Bart (Univ. Arkansas for Medical Sci., AR, USA) ,  SHAUGHNESSY John D.,Jr. (Univ. Arkansas for Medical Sci., AR, USA)
Material： International Journal of Hematology  (Int J Hematol)
Volume： 94  Issue： 4  Page： 321-333  Publication year： Oct. 2011 
JST Material Number： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  Document type： Article
Article type： 文献レビュー  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *Multiple Myeloma ,...
Semi thesaurus term： *pharmacogenomics

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1812674&from=J-GLOBAL&jstjournalNo=F0888A") }}

JST classification (3)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Diagnosis of tumors(=neoplasms)  (GE03020J) ,  Genetic variation  (EC01030Y)

Reference (76)：

• PALUMBO, A. Multiple myeloma. N Engl J Med. 2011, 364, 1046-1060
• BARLOGIE, B. Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myeloma. Clin Lymphoma Myeloma. 2006, 6, 469-474
• ANDERSON, KC. Oncogenomics to target myeloma in the bone marrow microenvironment. Clin Cancer Res. 2011, 17, 1225-1233
• PALUMBO, A. Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma : maintenance therapy and overall survival. Clin Cancer Res. 2011, 17, 1253-1263
• LONIAL, S. Treatment options for relapsed and refractory multiple myeloma. Clin Cancer Res. 2011, 17, 1264-1277

Terms in the title (7)： 多発性骨髄腫 ,  分子 ,  重症度分類 ,  予後予測 ,  個人 ,  治療 ,  ファーマコゲノミックス